TUZIL, Jan, Jana BARTAKOVA, Torquil WATT and Tomáš DOLEŽAL. Health-related quality of life in women with autoimmune thyroid disease during pregnancy and postpartum: systematic review including 321,850 pregnancies. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. ABINGDON: TAYLOR & FRANCIS LTD, 2021, vol. 21, No 6, p. 1179-1193. ISSN 1473-7167. Available from: https://dx.doi.org/10.1080/14737167.2021.1941882.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Health-related quality of life in women with autoimmune thyroid disease during pregnancy and postpartum: systematic review including 321,850 pregnancies
Authors TUZIL, Jan (203 Czech Republic, guarantor), Jana BARTAKOVA (203 Czech Republic), Torquil WATT (208 Denmark) and Tomáš DOLEŽAL (203 Czech Republic, belonging to the institution).
Edition EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, ABINGDON, TAYLOR & FRANCIS LTD, 2021, 1473-7167.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.039
RIV identification code RIV/00216224:14110/21:00123230
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1080/14737167.2021.1941882
UT WoS 000686823900001
Keywords in English Thyroid disease; pregnancy; postpartum; quality of life; depression; anxiety; utility; thyroid autoimmunity; thyroid disorder
Tags 14110516, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 13/12/2021 11:07.
Abstract
Background Utilities of the general population or expert estimates have been used for all published cost-effectiveness analyses of screening for thyroid disorders in pregnancy. Methods A systematic review CRD42019120897 of studies with patient-reported outcomes (PRO) and laboratory evidence of thyroid function/autoimmunity was conducted using PubMed, Cochrane Central, EconLit, SocIndex, DARE, NHS EEDS, Annual Reviews, and CINAHL. Quality was assessed using Joanna Briggs Institute appraisal tool. Results Of 664 abstracts screened, we analyzed 97 full texts. All studies describing the impact of thyroid disease on the generic QoL excluded pregnant and postpartum women. 21 reports of acceptable quality (321,850 pregnancies) determined depression and anxiety with validated tools and/or reported subjective symptoms. During pregnancy, contradictory conclusions were published on the impact of thyroid disease on PRO. Postpartum, antithyroid antibodies coincide with alexithymia and depression, postpartum thyroiditis negatively impacts mood. No conclusion could be drawn on the impact of thyroid hormonal levels. Conclusions The generic QoL in autoimmune thyroid disease during pregnancy has never been described, which represents an obstacle for the construction of economic models. We found contradictory information on the impact of thyroid disease on depression, anxiety, and specific symptoms.
PrintDisplayed: 21/6/2024 17:39